These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 13711834)

  • 1. Acromegaly treated by needle-implantation of AU198 seeds into the pituitary gland, showing changes in growth, carbohydrate and calcium metabolism.
    HARRISON MT; JOPLIN GF; HARTOG M; FRASER R
    Proc R Soc Med; 1960 Oct; 53(10):869-71. PubMed ID: 13711834
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.
    van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of diabetes mellitus but not acromegaly in a cat with a pituitary macroadenoma treated with hypofractionated radiation.
    Littler RM; Polton GA; Brearley MJ
    J Small Anim Pract; 2006 Jul; 47(7):392-5. PubMed ID: 16842276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the visual field induced by intrasellar implantation of 90Y in 104 acromegalic patients and their subsequent course].
    Liuzzi L; Dossi F
    Arch Sci Med (Torino); 1972; 129(4):252-72. PubMed ID: 17340698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short term use of octreotide in acromegaly.
    John M; Shah NS; Menon PS
    J Assoc Physicians India; 2005 May; 53():477-8. PubMed ID: 16124359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
    Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexisting acromegaly and primary empty sella syndrome.
    Hekimsoy Z; Yünten N; Sivrioglu S
    Neuro Endocrinol Lett; 2004 Aug; 25(4):307-9. PubMed ID: 15361823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11beta-hydroxysteroid dehydrogenase activity in acromegalic patients with normal or impaired carbohydrate metabolism.
    Mondok A; Varga I; Glaz E; Szucs N; Tóth M; Patocs A; Beko G; Racz K
    Steroids; 2009 Sep; 74(9):725-9. PubMed ID: 19540999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
    Wass JA
    J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegvisomant: new preparation. A last resort in acromegaly.
    Prescrire Int; 2005 Feb; 14(75):10-3. PubMed ID: 15751152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug insight: Primary medical therapy of acromegaly.
    Katznelson L
    Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):109-17; quiz following 117. PubMed ID: 16932265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current diagnostic guidelines for biochemical diagnosis of acromegaly.
    Ferone D; Resmini E; Bocca L; Giusti M; Barreca A; Minuto F
    Minerva Endocrinol; 2004 Dec; 29(4):207-23. PubMed ID: 15765030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silent growth hormone secreting pituitary adenomas: IGF-1 is not sufficient to exclude growth hormone excess.
    Kalavalapalli S; Reid H; Kane J; Buckler H; Trainer P; Heald AH
    Ann Clin Biochem; 2007 Jan; 44(Pt 1):89-93. PubMed ID: 17270100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment algorithm of acromegaly.
    Colao A; Pivonello R; Cappabianca P; Vitale G; Lombardi G
    J Endocrinol Invest; 2003; 26(8 Suppl):39-45. PubMed ID: 15233211
    [No Abstract]   [Full Text] [Related]  

  • 16. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly.
    Gradiser M; Matovinovic M; Vrkljan M
    Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is insulin growth factor-1 (IGF-1) playing a role for aneurysm formation in patients with pituitary gland tumor?
    Kulseng B; Myhre HO
    Int Angiol; 2006 Dec; 25(4):433-5. PubMed ID: 17164753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery.
    Höybye C; Chandramouli V; Efendic S; Hulting AL; Landau BR; Schumann WC; Wajngot A
    Horm Metab Res; 2008 Jul; 40(7):498-501. PubMed ID: 18393170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma Knife surgery after fractionated radiotherapy for acromegaly.
    Landolt AM; Lomax N; Scheib SG; Girard J
    J Neurosurg; 2006 Dec; 105 Suppl():31-6. PubMed ID: 18503327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryohypophysectomy used in the treatment of a case of feline acromegaly.
    Blois SL; Holmberg DL
    J Small Anim Pract; 2008 Nov; 49(11):596-600. PubMed ID: 18684148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.